Passer au contenu principal

Classement Rapports d'incident EU AI Act Académie Dilemmes

Signaler un incident

ALPARAITrust Infrastructure

Où le monde tient l'IA responsable.

Plateforme

Signalements
Classement
Dilemmes
Soumettre un rapport
Transparence
Dispositif du Tracker de l'AI
Défis

Entreprise

À propos
Conseil consultatif
Tarification
Sécurité
Académie
Kit de presse

Ressources

Blog
Méthodologie
GitHub
Documentation API

Juridique

Politique de confidentialité
Conditions d'utilisation
Politique de cookies
Politique DMCA
Politique de modération

Contact

hello@alparai.com
academy@alparai.com

© 2026 ALPAR AI. Open Source (AGPL-3.0). EU Hosted. GDPR + KVKK Compliant.

Plateforme intermédiaire. Contenu soumis par les utilisateurs.

Fil Rapports Classement À

Perplexity AI — Profil de marque · ALPAR AI

Perplexity AI

AI-powered answer engine.

Site web support@perplexity.ai

Profil non réclamé

Est-ce votre entreprise ? Réclamez ce profil - gratuitement

Réclamez ce profil pour répondre officiellement aux incidents, personnaliser les actifs de votre marque et accéder aux métriques des développeurs.

Profil de réclamation

4

Score de confiance

2

Nombre total d'incidents

0%

Taux de réponse

276

Moy. vues

Répartition de la gravité

Critique

2

Haut

0

Moyen

0

Faible

0

Statistiques rapides

Publié2

Réponses données0

Vues totales551

Réponse aux incidents0

Incidents signalés (2)

CritiquePubliéPerplexity AISLA N/ARapport utilisateurDésinformation

Publier de manière anonymeMay 2026

Perplexity cited non-existent academic paper

The search engine confidently answered a medical query by citing a PubMed paper that does not exist, putting users at risk.

Signalé

Révisé

Publié

28 mai 2026Moi aussi0 Commentaire0

by Publier de manière anonyme

CritiquePubliéPerplexity AISLA N/ARapport utilisateurAutre

Publier de manière anonymeJanuary 2026

Perplexity AI Reportedly Misstated CLL Research, Allegedly Contributing to Delayed Treatment and Prolonged Suffering

The author's father, a former neuroscientist with lung cancer, kidney disease, and Chronic Lymphocytic Leukemia (CLL), was diagnosed approximately 18 months before his death. His oncologist recommended Venetoclax-Obinutuzumab (Ven-Obi) treatment for the CLL, which is described as remarkably effective at extending patient life expectancy while reducing suffering. However, the father used Perplexity AI to self-diagnose his condition and became convinced he was experiencing Richter's Transformation, a rare CLL complication. Based on Perplexity's output, he believed he should refrain from the Ven-Obi treatment because it would make things worse. The author discovered this when given access to his father's medical records and found correspondence between his father and the frustrated oncologist that included the Perplexity report. The author contacted the researchers cited in Perplexity's response, who confirmed that Perplexity had misstated their research conclusions and that the father should follow his oncologist's recommendations. Despite being presented with this information, the father did not respond and only agreed to start the recommended treatment several months later after his condition had worsened dramatically. Although the treatment immediately reduced his white blood cell count, his pain continued and he died a few weeks later.

Signalé

Révisé

Publié

5 janv. 2026Moi aussi0 Commentaire0

by Publier de manière anonyme